Africa Capitalworks SSA 3

Africa Capitalworks SSA 3 is a Mauritius-based investment vehicle and a subsidiary of Africa Capitalworks Holdings (ACW). The company was established to acquire and manage a majority stake in Quality Chemical Industries Limited (QCIL), a leading pharmaceutical manufacturer in Sub-Saharan Africa. Through its subsidiary, the company focuses on the production of World Health Organization (WHO) pre-qualified generic medicines, primarily targeting infectious diseases such as HIV/AIDS, malaria, and hepatitis B. Operating from a state-of-the-art facility in Kampala, Uganda, the business serves as a critical supplier to national health programs and international donors across the region. Africa Capitalworks SSA 3 supports the strategic growth and regional expansion of local pharmaceutical manufacturing to improve healthcare self-sufficiency in Africa.